|
1
|
Watza D, Cote ML and Schwartz AG: Lung
Cancer: geneticseLS. John Wiley & Sons, Ltd.; Chichester: 2017,
View Article : Google Scholar
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wakeford R and Tawn EJ: Paternal
irradiation and leukemia in offspring. Radiat Res. 154:222–223.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pappa E, Nikitakis N, Vlachodimitropoulos
D, Avgoustidis D, Oktseloglou V and Papadogeorgakis N:
Phosphorylated signal transducer and activator of transcription-1
immunohistochemical expression is associated with improved survival
in patients with oral squamous cell carcinoma. J Oral Maxillofac
Surg. 72:211–221. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Leeman RJ, Lui VW and Grandis JR: STAT3 as
a therapeutic target in head and neck cancer. Expert Opin Biol
Ther. 6:231–241. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Proietti C, Salatino M, Rosemblit C,
Carnevale R, Pecci A, Kornblihtt AR, Molinolo AA, Frahm I, Charreau
EH, Schillaci R, et al: Progestins induce transcriptional
activation of signal transducer and activator of transcription 3
(Stat3) via a Jak- and Src-dependent mechanism in breast cancer
cells. Mol Cell Biol. 25:4826–4840. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gonçalves J and Silva AP: Methamphetamine
and the JAK/STAT pathwayNeuropathology of Drug Addictions and
Substance Misuse. Preedy VR: 2. 1st edition. Academic Press;
Cambridge, MA: pp. 147–154. 2016, View Article : Google Scholar
|
|
8
|
Schütz A, Röser K, Klitzsch J, Lieder F,
Aberger F, Gruber W, Mueller KM, Pupyshev A, Moriggl R and
Friedrich K: Lung adenocarcinomas and lung cancer cell lines show
association of MMP-1 expression with STAT3 activation. Trans Oncol.
8:97–105. 2015. View Article : Google Scholar
|
|
9
|
de la Bellacasa Puig R, Karachaliou N,
Estrada-Tejedor R, Teixidó J, Costa C and Borrell JI: ALK and ROS1
as a joint target for the treatment of lung cancer: A review.
Transl Lung Cancer Res. 2:72–86. 2013.PubMed/NCBI
|
|
10
|
Xu W, Kim JW, Jung WJ, Koh Y and Yoon SS:
Crizotinib in combination with everolimus synergistically inhibits
proliferation of ALK-positive anaplastic large cell lymphoma.
Cancer Res Treat. Jun 19–2017.(Epub ahead of print). https://doi.org/10.4143/crt.2016.357
|
|
11
|
Adlakha YK and Saini N: MicroRNA: A
connecting road between apoptosis and cholesterol metabolism.
Tumour Biol. 37:8529–8554. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Han Y, Park S, Kinyua AW, Andera L, Kim KW
and Kim I: Emetine enhances the tumor necrosis factor-related
apoptosis-inducing ligand-induced apoptosis of pancreatic cancer
cells by downregulation of myeloid cell leukemia sequence-1
protein. Oncol Rep. 31:456–462. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ahn HK, Jeon K, Yoo H, Han B, Lee SJ, Park
H, Lee MJ, Ha SY, Han JH, Sun JM, et al: Successful treatment with
crizotinib in mechanically ventilated patients with ALK positive
non-small-cell lung cancer. J Thorac Oncol. 8:250–253. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Roth W: Cell death in malignant tumors.
Relevance of cell death regulation for metastasis. Pathologe. 36
Suppl 2:181–184. 2015.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Song X, Zhang Z, Wang S, Li H, Zuo H, Xu
X, Weng S, He J and Li C: A Janus Kinase in the JAK/STAT signaling
pathway from Litopenaeus vannamei is involved in antiviral immune
response. Fish Shellfish Immunol. 44:662–673. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee TS, Kantarjian H, Ma W, Yeh CH, Giles
F and Albitar M: Effects of clinically relevant MPL mutations in
the transmembrane domain revealed at the atomic level through
computational modeling. PLoS One. 6:e233962011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rozovski U, Wu JY, Harris DM, Liu Z, Li P,
Hazan-Halevy I, Ferrajoli A, Burger JA, O'Brien S, Jain N, et al:
Stimulation of the B-cell receptor activates the JAK2/STAT3
signaling pathway in chronic lymphocytic leukemia cells. Blood.
123:3797–3802. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jiang J, Liu Y, Tang Y, Li L, Zeng R, Zeng
S and Zhong M: ALDH1A1 induces resistance to CHOP in diffuse large
B-cell lymphoma through activation of the JAK2/STAT3 pathway. Onco
Targets Ther. 9:5349–5360. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jiang R, Wang X, Jin Z and Li K:
Association of nuclear PIM1 expression with lymph node metastasis
and poor prognosis in patients with lung adenocarcinoma and
squamous cell carcinoma. J Cancer. 7:324–334. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chu Q, Shen D, He L, Wang H, Liu C and
Zhang W: Prognostic significance of SOCS3 and its biological
function in colorectal cancer. Gene. 627:114–122. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xue F, Zhu L, Meng QW, Wang L, Chen XS,
Zhao YB, Xing Y, Wang XY and Cai L: FAT10 is associated with the
malignancy and drug resistance of non-small-cell lung cancer. Onco
Targets Ther. 9:4397–4409. 2016. View Article : Google Scholar : PubMed/NCBI
|
